{"id":"W2594646846","doi":"10.1016/s2352-3026(17)30019-4","title":"Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Health Services","funders":"Gilead Sciences; Lymphoma Research Foundation","keywords":"Ofatumumab; Idelalisib; Medicine; Internal medicine; Population; IGHV@; Clinical endpoint; Chronic lymphocytic leukemia; Ibrutinib; Rituximab; Clinical trial; Oncology; Gastroenterology; Lymphoma; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001584072,0.0002198868,0.001724924,0.0001029663,0.0002464803,0.00007001057,0.0007707727,0.0001904068,0.00002600506],"category_scores_gemma":[0.001048952,0.0001371361,0.00003404752,0.0001139631,0.0006956849,0.0002139,0.0002065068,0.0002160793,0.000003488107],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004436193,"about_ca_system_score_gemma":0.006014132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001073926,"about_ca_topic_score_gemma":0.0006607085,"domain_scores_codex":[0.997902,0.0003158682,0.000586253,0.0004204661,0.000237769,0.0005376393],"domain_scores_gemma":[0.9970899,0.0008770184,0.0004428757,0.001317585,0.0001530048,0.0001196272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9847146,0.00103292,0.0001303629,0.0008155611,0.0002201241,0.000223773,0.0006057353,0.00002356741,0.001168962,0.004400827,0.0004072657,0.006256248],"study_design_scores_gemma":[0.964321,0.007899914,0.0002159866,0.0004023568,0.0002616615,0.0008493622,0.00003370324,0.0230432,0.00215308,0.0004374424,0.0002368934,0.000145382],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892958,0.0005368013,0.0001529856,0.001093879,0.00007324645,0.008108146,0.00001659135,0.00003067535,0.0006918124],"genre_scores_gemma":[0.9983819,0.0003228632,0.000285763,0.00009260706,0.000128932,0.0005162674,0.00007868112,0.00003803808,0.0001549214],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02301963,"threshold_uncertainty_score":0.9996209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09379685803426602,"score_gpt":0.4174588566744332,"score_spread":0.3236619986401672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}